PARTNER NEWS:Thu, Mar 28, 7:54 AM, Zacks
Syndax (SNDX) Gets FDA Priority Tag for Leukemia Drug NDA Syndax Pharmaceuticals (SNDX) groundbreaking menin inhibitor, revumenib, receives FDA priority review for treating relapsed, refractory acute leukemia.
Mon, Feb 26, 7:50 AM, Zacks
Syndax (SNDX) is on the Move, Here's Why the Trend Could be Sustainable Syndax (SNDX) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks that passed through our shorter-term trading strategy-based screen.
Featured MNV Articles: COMPASS Pathways (CMPS) Shares Cross Below 200 DMA
Thursday, April 18, 4:58 PM ET, by Market News Video Staff
In trading on Thursday, shares of COMPASS Pathways plc (CMPS) crossed below their 200 day ...
AnaptysBio Breaks Below 200-Day Moving Average - Notable for ANAB
Thursday, April 18, 4:56 PM ET, by Market News Video Staff
In trading on Thursday, shares of AnaptysBio Inc (ANAB) crossed below their 200 day moving ...
Notable Two Hundred Day Moving Average Cross - CERT
Thursday, April 18, 4:56 PM ET, by Market News Video Staff
In trading on Thursday, shares of Certara Inc (CERT) crossed below their 200 day moving ...
WhiteHorse Finance Breaks Above 200-Day Moving Average - Bullish for WHF
Thursday, April 18, 4:46 PM ET, by Market News Video Staff
In trading on Thursday, shares of WhiteHorse Finance Inc. (WHF) crossed above their 200 day ...
RBC Bearings Enters Oversold Territory
Thursday, April 18, 4:45 PM ET, by Market News Video Staff
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy ...
|
|
By Dividend Channel Staff, Wednesday, December 31, 7:00 PM ET
|